Home Trending Stocks What Is Driving Reviva (RVPH) Stock 62% Higher Today?

What Is Driving Reviva (RVPH) Stock 62% Higher Today?

On the last check Monday, Reviva Pharmaceuticals Holdings Inc. (RVPH) rose 61.97% to $6.90 in the current market.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

The Reviva stock closed at $4.32 on Friday. A price range of $4.16 to $4.34 was observed for RVPH stock in that session. On the release of the lead drug candidate’s trial data, RVPH stock is trending upward.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

What the study data has found?

Revivva is the therapeutic company devoted to discovering, developing and commercializing next-generation therapeutics for diseases with great unmet medical need and burden of society, patients and their families. Research at RVPH is primarily focused on neurological, respiratory and metabolic diseases. The RVPH pipeline consists of two drug candidates: RP5063 (brilaroxazine) and RP1208. Both have been discovered in-house.

Today, Reviva Pharmaceuticals announced details of its Phase 2 clinical trial for RP5063 (brilaroxazine), a candidate drug for Acute Schizophrenia.

  • RVPH believes that Brilaroxazine modulates and stabilizes the serotonin (5-HT) and dopamine (D) receptors via its unique pharmacology profile against these receptors.
  • This research shows Brilaroxazine binds to key serotonin receptors with high affinity.
  • With its combination of high affinity and selectivity for target receptors implicated in schizophrenia, Brilaroxazine by RVPH is pharmacologically different from other antipsychotics.
  • An RVPH Phase 2 trial was initiated to assess brilaroxazine safety and efficacy in 234 patients with acute exacerbations of schizophrenia.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

How the RVPH candidate performed?

The Reviva (RVPH) study concluded that brilaroxazine met its primary endpoint, which was a reduction in the PANSS total score at the end of treatment, compared to the placebo. Also, RVPH’s drug candidate was well tolerated in clinical, lab, and body weight studies, as well as in lipid, glucose, and EKG tests. Statistically significant treatment difference from the placebo resulted in a 20-point decrease in PANSS total scores in RVPH study.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam